4.3 Article

Incomplete response to therapy in intermediate- and high-risk thyroid cancer

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Optimal cutoff values of primary tumour size to better predict long-term outcomes in patients with papillary thyroid carcinoma undergoing total thyroidectomy: A preliminary study using restricted cubic spline analysis

Sung Woo Jang et al.

Summary: The study determined new optimal cutoff values for PTS as 1.4 and 3.0 cm, which significantly stratified patients with PTC for target outcomes. Subgroups classified using these newly determined cutoff values showed significantly different recurrence-free survival and response-to-therapy categories compared to subgroups classified using the cutoff values of 2 and 4 cm.

CLINICAL ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Assessment of age as different variable types for determining survival in differentiated thyroid cancer

Li Genpeng et al.

Summary: The study aimed to explore the concept of using age as a continuous variable for predicting outcomes in differentiated thyroid cancer (DTC) patients. By comparing survival rates and constructing a nomogram, the study found that using age as a continuous variable has a rational predictive effect on DTC patients.

ENDOCRINE (2022)

Article Endocrinology & Metabolism

How Does The AJCC/TNM Staging System Eighth Edition Perform in Thyroid Cancer at A Major Middle Eastern Medical Center?

Ali S. Alzahrani et al.

Summary: This study compared the TNM-7 and TNM-8 staging systems for differentiated thyroid cancer (DTC) in a Middle Eastern population, showing that TNM-8 downstaged approximately a quarter of patients and was more accurate in predicting outcomes at different stages.

ENDOCRINE PRACTICE (2021)

Article Endocrinology & Metabolism

Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer

Evert F. S. van Velsen et al.

Summary: This study investigated the optimal age cutoff for the TNM staging system in differentiated thyroid cancer, finding that for DTC overall and PTC patients, an age cutoff of 50 years had the best statistical model performance, while it was 40 years for FTC patients. This suggests that implementing different age cutoffs for PTC and FTC could improve the predictive value of the TNM staging system.

THYROID (2021)

Article Endocrinology & Metabolism

Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid Cancer

Noha Mukhtar et al.

Summary: The concept of response to therapy in differentiated thyroid cancer (DTC) serves as a dynamic risk stratification for assessing disease status and future recurrence risk. This study evaluated the natural course of different response statuses over time in 501 DTC patients. The response to therapy at the initial evaluation is predictive of long-term outcomes, with mortality and progression primarily occurring in the structurally incomplete status.

EUROPEAN THYROID JOURNAL (2021)

Article Oncology

Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease

Eman A. Toraih et al.

Summary: The study examined the impact of different distant metastasis sites on the survival of PTC patients and found that metastasis to specific organs can significantly affect prognosis. Patients with brain and liver metastases had lower 5-year survival rates compared to those with bone and liver metastases, with risk factors such as male gender, multiple organ involvement, and brain metastasis influencing overall survival. Clinicians should consider these factors when developing treatment strategies.

CANCERS (2021)

Article Endocrinology & Metabolism

Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer

Ali S. Alzahrani et al.

Summary: A study of 506 patients with low and intermediate-risk DTC found that the majority had favorable outcomes, while age and lateral lymph node metastasis were strong predictors of incomplete response to therapy.

JOURNAL OF THE ENDOCRINE SOCIETY (2021)

Article Endocrinology & Metabolism

Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer

Fernanda Vaisman et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2019)

Review Endocrinology & Metabolism

Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up

R. Michael Tuttle et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Endocrinology & Metabolism

Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence

Sona Shah et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?

Ian Ganly et al.

THYROID (2015)

Article Endocrinology & Metabolism

The Impact of Age and Gender on Papillary Thyroid Cancer Survival

J. Jonklaas et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Otorhinolaryngology

Reevaluating the Prognostic Significance of Age in Differentiated Thyroid Cancer

Samuel L. Oyer et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2012)

Article Oncology

Differentiated thyroid carcinoma with distant metastases: Probability of survival and its predicting factors

Jasna Mihailovic et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)

Review Surgery

Staging systems for papillary thyroid carcinoma - A review and comparison

Brian Hung-Hin Lang et al.

ANNALS OF SURGERY (2007)

Article Endocrinology & Metabolism

Survival and death causes in differentiated thyroid carcinoma

CFA Eustatia-Rutten et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)